Sun 12/16/2018 10:43 ET
DJIA24100.51486.832.02%TELCO165.080.660.40%GOLD1242.305.090.41%Shanghai2593.7439.681.53%
S&P 5002599.9549.661.91%BANKS395.493.760.95%OIL51.231.352.64%BITCOIN3266.0530.700.94%
NASDAQ6910.67156.182.26%PHARM563.0727.874.95%US/EU1.130.000.01%Futures2605.500.000.00%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neovasc - NVCN   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NVCN
  
From: kyleLennon (Rep: 0)Date: 08/07/2018 11:07
Forum: Neovasc - Msg #652Thread #674026455 (Rec: 0)
Just yesterday Neovasc resolved potential legal claims that could be brought against the company with the University of Pennsylvania (a.k.a. Penn). The firm has signed a collaboration and licensing agreement with Penn's Gorman Cardiovascular Research Group. Based on the agreement, for a period of time over the next four years Neovasc will pay a fee to Penn. The company will also pay a royalty on Tiara, its cornerstone product, to Penn. This agreement does not impact either Penn's or Neovasc's patent rights, and it also contains buyout clauses which allow a potential acquirer to buy out the royalty obligations.

NVCN: https://www.finstead.com/bite/Neovasc-NVCN-stock-forecast-prediction-august-4-2018

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser kyleLennon: Reward | Watch | IgnoreNVCN: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NVCN
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.